Citigroup’s Korro Bio KRRO Stock Holding History
Bought
Maintained
Sold
Other funds holding KRRO
PFSRSONJ
NSIM
GI
TWC
VCM
EWA
DSC
IA
Citigroup's KRRO Position: Q2 2026 in Review
Citigroup increased its Korro Bio (KRRO) stake by 1,578% in Q2 2026, buying an estimated $60.4K and bringing the position to 5,169 shares worth $68.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4873.
Citigroup first reported a position in KRRO in Q4 2019 and has held it in 23 quarters since. The position peaked at $1.74M in Q1 2024. 17 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.
- Citigroup held 5,169 shares of Korro Bio worth $68.1K as of Q2 2026.
- Citigroup bought 4,861 Korro Bio shares in Q2 2026, an estimated $60.4K.
- Korro Bio made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4873 holding.
- Citigroup first reported a position in Korro Bio in Q4 2019 and has held it in 23 quarters since.
- Citigroup's Korro Bio position peaked at $1.74M in Q1 2024.
- 17 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.